Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

计划入组 146 人 · 首次发布于 2025 年 6 月 8 日

Role of Nox2 in CNI-induced Renal Fibrosis

计划入组 8 人 · 首次发布于 2012 年 8 月 28 日

A Study to Evaluate Renal Fibrosis Using MRI Techniques

计划入组 24 人 · 首次发布于 2020 年 8 月 11 日

Renal Fibrosis(Hepion)

Cyclophilin D inhibitors (renal fibrosis)

LPAR1-targeting siRNA (lipid nanoparticle, renal fibrosis)

Cystic Fibrosis Foundation

United States

River 3 Renal Corp.

United States

Southeast Renal Research Institute

United States

Nanomedicine-Driven Precision Therapy for Renal Fibrosis: Bridging Molecular Mechanisms and Targeted Delivery

Novel GCGR/GLP-1R Dual Agonist TB001 Shows Promise for Treating Kidney Fibrosis

Algernon Pharmaceuticals Secures European Patent for Repirinast in Kidney Disease Treatment